Study: NCT02212730

Adverse event: Infections and infestations
Serious: yes
Organ System: Infections and infestations
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Eye disorders
Serious: no
Organ System: Eye disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: General disorders and administration site conditions
Serious: no
Organ System: General disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: General disorders and administration site conditions
Serious: no
Organ System: General disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Investigations
Serious: no
Organ System: Investigations
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Musculoskeletal and connective tissue disorders
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Nervous system disorders
Serious: no
Organ System: Nervous system disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Skin and subcutaneous tissue disorders
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 4 at risk

Adverse event: Metabolism and nutrition disorders
Serious: yes
Organ System: Metabolism and nutrition disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: General disorders and administration site conditions
Serious: no
Organ System: General disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Metabolism and nutrition disorders
Serious: no
Organ System: Metabolism and nutrition disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Skin and subcutaneous tissue disorders
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Skin and subcutaneous tissue disorders
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: General disorders and administration site conditions
Serious: no
Organ System: General disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Investigations
Serious: no
Organ System: Investigations
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Musculoskeletal and connective tissue disorders
Serious: no
Organ System: Musculoskeletal and connective tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk

Adverse event: Skin and subcutaneous tissue disorders
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Due to the small sample size for this study, we are not disclosing the specific Adverse Event term for this Adverse Event due to patient confidentiality concerns.
Frequency: 1 affected / 1 at risk